Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. CommentaryFURMAN, Mark I; KRUEGER, Lori A; LINDEN, Matthew D et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 12, pp 2319-2328, issn 0735-1097, 10 p.Article

Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)REBEIZ, Abdallah G; JOHANSON, Per; TOPOL, Eric J et al.The American journal of cardiology. 2005, Vol 95, Num 5, pp 611-614, issn 0002-9149, 4 p.Article

PROFOUND THROMBOCYTOPENIA WITH GLYCOPROTEIN IIb/IIIa INHIBITORS PLUS HEPARIN FOR PUMP THROMBUS. Authors' replyBLAIS, Danielle M; SUN, Benjamin; VESCO, Paul et al.The Journal of heart and lung transplantation. 2008, Vol 27, Num 12, pp 1361-1362, issn 1053-2498, 2 p.Article

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the replace-2 trial)CHEW, Derek P; LINCOFF, A. Michael; GURM, Hitinder et al.The American journal of cardiology. 2005, Vol 95, Num 5, pp 581-585, issn 0002-9149, 5 p.Article

Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregationFRELINGER, Andrew L; FURMAN, Mark I; BARNARD, Marc R et al.The American journal of cardiology. 2003, Vol 92, Num 9, pp 1099-1101, issn 0002-9149, 3 p.Article

Novel method to dissociate platelet clumps in EDTA-dependent pseudothrombocytopenia based on the pathophysiological mechanismCHAE, Hyojin; KIM, Myungshin; LIM, Jihyang et al.Clinical chemistry and laboratory medicine. 2012, Vol 50, Num 8, pp 1387-1391, issn 1434-6621, 5 p.Article

Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stentingCHAN, Albert W; YADAV, Jay S; BHATT, Deepak L et al.The American journal of cardiology. 2005, Vol 95, Num 6, pp 791-795, issn 0002-9149, 5 p.Article

The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors : The Do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trialBERGER, Peter B; BEST, Patricia J. M; TOPOL, Eric J et al.The American heart journal. 2005, Vol 149, Num 5, pp 869-875, issn 0002-8703, 7 p.Article

Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitorsDIXON, S. R.Heart. Supplement. 2005, Vol 91, Num 3, pp iii2-iii6Article

Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary interventionDAY, J. R. S; MALIK, I. S; WEERASINGHE, A et al.Heart (London 1996). 2004, Vol 90, Num 7, pp 794-799, issn 1355-6037, 6 p.Article

Nonsense mutation in exon-19 of GPIIb associated with thrombasthenic phenotype. Failure of GPIIb(Δ597-1008) to form stable complexes with GPIIIaARIAS-SALGADO, Elena G; JIANMING TAO; GONZALEZ-MANCHON, Consuelo et al.Thrombosis and haemostasis. 2002, Vol 87, Num 4, pp 684-691, issn 0340-6245Article

Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonistsHUXTABLE, Lindsay M; TAFRESHI, Mohammad J; RAKKAR, Amol N. S et al.The American journal of cardiology. 2006, Vol 97, Num 3, pp 426-429, issn 0002-9149, 4 p.Article

Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous coronary interventionROBERTSON, Jason O; LINCOFF, A. Michael; WOLSKI, Kathy et al.The American journal of cardiology. 2006, Vol 97, Num 12, pp 1679-1684, issn 0002-9149, 6 p.Article

Enoxaparin and glycoprotein IIb/IIIa inhibition in non-ST-elevation acute coronary syndrome : Insights from the INTERACT trialGOODMAN, Shaun.The American heart journal. 2005, Vol 149, Num 4, pp S73-S80, issn 0002-8703, SUPConference Paper

Switch from abciximab to eptifibatide during percutaneous coronary interventionWAHLIN, Magnus; ALBERTSSON, Per; KARLSSON, Thomas et al.International journal of cardiology. 2009, Vol 134, Num 3, pp 393-400, issn 0167-5273, 8 p.Article

The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromesKOLLER, Colleen F.Heart & lung. 2001, Vol 30, Num 5, pp 321-331, issn 0147-9563Article

Safety of Intra-aortic Balloon Pump Using Glycoprotein IIb/IIIa AntagonistsLAISH-FARKASH, Avishag; HOD, Hanoch; MATETZKY, Shlomo et al.Clinical cardiology (Mahwah, NJ). 2009, Vol 32, Num 2, pp 99-103, issn 0160-9289, 5 p.Article

The clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: ReoPro)-coated stent in acute myocardial infarctionKIM, Weon; MYUNG HO JEONG; DONG LYUN CHO et al.Journal of the American College of Cardiology. 2006, Vol 47, Num 5, pp 933-938, issn 0735-1097, 6 p.Article

Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIa inhibition in acute myocardial infarction : the RADIAL-AMI pilot randomized trialCANTOR, Warren J; PULEY, Geoff; CHISHOLM, Robert J et al.The American heart journal. 2005, Vol 150, Num 3, pp 543-549, issn 0002-8703, 7 p.Article

Optimal utilization of glycoprotein IIb/IIIa-receptor inhibitors: evolving considerations and evidenceRACINE, Eric.American journal of health-system pharmacy. 2002, Vol 59, issn 1079-2082, 45 p., SUP7Serial Issue

A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIaLOSONCZY, Gergely; ROSENBERG, Nurit; KISS, Csongor et al.Thrombosis and haemostasis. 2005, Vol 93, Num 5, pp 904-909, issn 0340-6245, 6 p.Article

Considerations in combination therapy: Fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarctionMANOHARAN, Ganesh; ADGEY, A. A.Clinical cardiology (Mahwah, NJ). 2004, Vol 27, Num 7, pp 381-386, issn 0160-9289, 6 p.Article

Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation : an individual patient data meta-analysisDE LUCA, G; GIBSON, C. M; GABRIEL, H. M et al.Heart (London 1996). 2008, Vol 94, Num 12, pp 1548-1558, issn 1355-6037, 11 p.Article

Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor useSABATINE, Marc S; HAMDALLA, Hussam N; MEHTA, Shamir R et al.The American heart journal. 2008, Vol 155, Num 5, pp 910-917, issn 0002-8703, 8 p.Article

Successful Treatment of Rotary Pump Thrombus With the Glycoprotein IIb/IIIa Inhibitor TirofibanTHOMAS, Martin D; WOOD, Clare; LOVETT, Mike et al.The Journal of heart and lung transplantation. 2008, Vol 27, Num 8, pp 925-927, issn 1053-2498, 3 p.Article